FDA Inspection 1121945 — Acucon

Acucon — FEI 3005184723

The FDA completed an inspection of Acucon on February 28, 2020 in Sarasota, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 28, 2020
Fiscal Year
2020
Product Type
Devices
Project Area
Compliance: Devices
Location
Sarasota, FL (United States)

Citations

IDCFRDescription
311821 CFR 820.75(a)Documentation